ApoA2 Drives Metastasis and Drug Resistance in Liver Cancer Through HMGB1/IL-17A Signaling
New research shows that the blood lipid protein ApoA2 promotes metastasis and chemotherapy resistance in hepatocellular carcinoma by activating an ...
New research shows that the blood lipid protein ApoA2 promotes metastasis and chemotherapy resistance in hepatocellular carcinoma by activating an ...
A new review in Molecular Cancer details how five classes of nanomaterials could breach the blood–brain barrier and dismantle the ...
A new study of 90 AML patients shows that apoptosis gene expression patterns define two biologically distinct leukemia subgroups with ...
The largest genomic survey of tuberculosis in Ukraine to date shows that drug-resistant disease is overwhelmingly driven by a few ...
A Ugandan verification study found the Deeplex Myc-TB targeted sequencing assay achieved perfect specificity and strong sensitivity for key tuberculosis ...
New preclinical research shows that the ATR inhibitor ceralasertib (AZD6738) synergistically restores and amplifies the antitumor activity of trifluridine in ...
A major new review shows that long non-coding RNAs orchestrate the colorectal cancer tumour microenvironment, offering new biomarkers and therapeutic ...
A new review maps the fast-moving landscape of next-generation KRAS inhibitors, degraders, and combination strategies now advancing beyond the first ...
A new review in npj Viruses argues that host RNA-binding proteins, which many unrelated viruses hijack during replication, could serve ...
Low-dose inhibition of the motor protein KIF11 rebuilds enhancer–promoter loops at the androgen receptor locus, restoring drug sensitivity in otherwise ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine